CEO Since 2013
The company has return on total asset (ROA) of (21.6) % which means that it has lost $21.6 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (51.33) % meaning that it generated substantial loss on money invested by shareholders.
The company has accumulated 477.23 K in total debt with debt to equity ratio (D/E) of 0.17 which may suggest the company is not taking enough advantage from borrowing. Algae Biosciences Corporation has Current Ratio of 0.03 indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due.
Entity SummaryWard Marlatte, Chief Exec. Officer, Sec. and DirectorN/AN/AMr. Marc Joseph Stachiw, Interim Chief Financial Officer and DirectorN/AN/AMr. Anthony H. Smith, 46Exec.N/A0.00 Wayne M. Tinker, Exec.N/A0.00Algae Biosciences Corporation [AGBCF] is traded on OTC Market in USA. It is located in , except where noted. and employs 5 people.
Filter other executives
Algae Biosciences CorporationUSA StockCurrency: USD - US DollarTraded on OTC Market
Fix Your Portfolios with Algae
Algae Biosciences Leadership